Thomas C. Freyman, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 9,655 shares at $53.92 ($460K) on 2010-02-16, disclosed to the SEC on 2010-02-18.
Scheduled sale ($460k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,122 | $0 | 0.0% |
| 2 | $53.92 | 500 | $27K | 5.9% |
| 3 | $53.92 | 700 | $38K | 8.2% |
| 4 | $53.92 | 900 | $49K | 10.5% |
| 5 | $53.93 | 6,433 | $347K | 75.4% |
| Total | $47.66 avg | 9,655 |
| $460K |
| 100% |
| Filing → |
| TEN | BUY | 2018-08-10 | $222K | — | Filing → |
| ABT | SELL | 2014-03-04 | $117K | — | Filing → |
| TEN | BUY | 2013-05-03 | $57K | — | Filing → |